(Q39178068)

9 September 2017

title

Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy (English)

1 reference

9 September 2017

1 reference

1 reference

J-W Choi

1

1 reference

9 September 2017

E Kang

2

1 reference

9 September 2017

O-J Kwon

3

1 reference

9 September 2017

T J Yun

4

1 reference

9 September 2017

H-K Park

5

1 reference

9 September 2017

P-H Kim

6

1 reference

9 September 2017

S W Kim

7

1 reference

9 September 2017

J H Kim

8

1 reference

9 September 2017

C-O Yun

9

1 reference

9 September 2017

publication date

21 March 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

20

1 reference

9 September 2017

issue

9

1 reference

9 September 2017

page(s)

880-892

1 reference

Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Conditionally replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Replication-selective adenoviruses as oncolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Development of stable liquid formulations for adenovirus-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Oncolytic adenoviruses expressing interleukin: a novel antitumour approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Adenoviral gene delivery to solid tumors by recombinant silk-elastinlike protein polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Adenovirus BMP2-induced osteogenesis in combination with collagen carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Localized adenovirus gene delivery using antiviral IgG complexation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Novel therapeutic strategy for prevention of malignant tumor recurrence after surgery: Local delivery and prolonged release of adenovirus immobilized in photocured, tissue-adhesive gelatinous matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Silk-elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Oncolytic virotherapy for cancer treatment: challenges and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

The innate immune response to adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

7 January 2021

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

7 January 2021

Tuneable semi-synthetic network alginate for absorptive encapsulation and controlled release of protein therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

7 January 2021

Adenoviral vectors stimulate murine natural killer cell responses and demonstrate antitumor activities in the absence of transgene expression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.10

7 January 2021

Identifiers

DOI

10.1038/GT.2013.10

1 reference

9 September 2017

1 reference